1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
HORIZON-JU-EDCTP3-2026-Scientific Leadership Man SSA Prize is sponsored by European Commission — Horizon Europe. Objective: 1. Background The EDCTP Prizes 2026-2027 are recognition prizes funded under Horizon Europe. Prizes are financial contributions given as rewards following the publication of a contest. A ‘recognition prize’ is used to recognise past achievements and outstanding work after it has been performed, whereas an ‘inducement prize’ is used to spur investment in a given direction, by specifying a target prior to the performance of the work. Applications will have to clearly state the involvement of the applicants in the research and innovation activities within the remit of the Global Health EDCTP3 programme. Applicants will have to provide proof of eligibility and a written presentation of the achievements, which will be presented to an independent panel of experts for evaluation. The amounts of the prizes are specified in section 3. They are not linked to the costs incurred by the winner. 2. EDCTP3 Prizes 2026 and related award criteria The prizes will be awarded to the entry that, in the opinion of the independent expert jury, demonstrates having best addressed the cumulative criteria specified under the respective descriptions below. Applications will be graded on a total of 100 points. Where relevant, the number of points for each award criterion is indicated below. Scientific Leadership Prize (four prizes) These prizes will be awarded to four different profiles and aim to recognise growing mid-career scientists: - Two Scientific Leadership Prizes (one woman and one man) for researchers who are permanent residents of an EU Member State or a country associated with the Horizon Europe programme; - Two Scientific Leadership Prizes (one woman and one man) for researchers who are permanent residents of a sub-Saharan African country which is a constituent state of the EDCTP Association. Award criteria These prizes are awarded to the entries that best address the following cumulative criteria based on their application, that should also include a letter of support from other member(s) of the research community: Scientific contribution and excellence: Contestants should have made significant achievements in their field and will continue to be leaders in their research field (50 points). Impact: Contestants should have made major contributions to the objectives of the Global Health EDCTP3 programme to strengthen research capacity in sub-Saharan Africa and to support South-South and North-South networking (50 points). 3. Available budget The prizes budget is: Four Scientific Leadership prizes: EUR 15,000 each. 4. Timetable and deadlines As indicated in the Funding & Tenders Portal. Additional information on the Global Health EDCTP3 site 5. Admissibility and documents Applications must be submitted before the contest deadline . Applications must be submitted electronically via the Funding & Tenders Portal Electronic Submission System (accessible via the Topic page in the Search Funding & Tenders section). Paper submissions are NOT possible. Applications (including annexes and supporting documents) must be submitted using the forms provided inside the Submission System ( NOT the documents available on the Topic page — they are only for information). Applications must be complete and contain all the requested information and all required annexes and supporting documents: Application Form Part A — contains administrative information about the applicant (to be filled in directly online) Application Form Part B — contains the technical description of the application (to be downloaded from the Portal Submission System, completed and then assembled and re-uploaded) mandatory annexes and supporting documents (to be uploaded) : letter(s) of support from a reputable scientist and short CV of the person providing the letter. CV of the applicant(s). Your application must be readable , accessible and printable . Applications are limited to maximum 45 pages (Part B). Evaluators will not consider any additional pages. The application
Programme areas: Global Challenges and European Industrial Competitiveness, Horizon Europe (HORIZON), Health
Keywords: Africa, EDCTP3, Scientific Leadership, edctp
Get alerted about grants like this
Get emailed when new opportunities from “European Commission — Horizon Europe” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Open to legal entities established in EU Member States and countries associated to Horizon Europe (including EEA/EFTA countries, and other associated third countries). Action type: HORIZON-RPr HORIZON Recognition Prize. Additional conditions: "> General conditions 1. Admissibility conditions: Proposal page limit and layout described in Rules of Contest 2. Eligible countries described in Rules of Contest 3. Other Eligibility Conditions described in Rules of Contest 4. Financial and operational capacity and exclusion described in Rules of Contest 5a. Evaluation and award: Award criteria, scoring and thresholds described in Rules of Contest 5b. Evaluation and award: Submission and evaluation processes described in Rules of Contest 5c.... See the official call documentation on the F&T Portal for full eligibility criteria and participation rules. Confirm the full requirements in the official notice before applying.
Applications for HORIZON-JU-EDCTP3-2026-Scientific Leadership Man SSA Prize are due September 2, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
HORIZON-JU-EDCTP3-2026-Scientific Leadership Man SSA Prize is funded by European Commission — Horizon Europe. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
EIC 2026 Pathfinder Open is sponsored by European Commission — Horizon Europe. Expected Impact: The expected output of your project is the proof of principle that the main ideas of the envisioned future technology are feasible, thus validating its scientific and technological basis. Project results should include top-level scientific publications in open access. While your vision is expected to be worthwhile because of its potential for future impact, for instance to create new markets, improve our lives, or provide solutions for global challenges, these are not expected to be achieved in the course of your EIC Pathfinder Open project. However, you are expected to take the necessary measures in the course of the project to allow future uptake to take place. This includes: an adequate formal protection of the generated Intellectual Property (IP), a plan for future exploitation and an assessment of relevant aspects related to regulation, certification, and standardisation. In addition, you are encouraged to involve and empower in your team key actors that have the potential to become future leaders in their field such as excellent early-career researchers or promising high-tech SMEs, including start-ups. Your project should reinforce their mind-set for targeted research and development aimed at high impact applied results. This will strengthen Europe’s capacity for exploiting the scientific discoveries made in Europe throughout the steps to market success or for solving global challenges. You are particularly encouraged to empower female researchers in your project and to achieve gender balance among your work package leaders. Objective: The overall objective of the EIC Pathfinder for advanced research is to develop the scientific basis to underpin breakthrough technologies. It provides support for the earliest stages of scientific, technological or deep tech research and development. Pathfinder projects aim to build on new, cutting-edge directions in science and technology to disrupt a field and a market or create new opportunities by realising innovative technological solutions through: ‘EIC Pathfinder Open’, open to support projects in any field of science, technology or application without predefined thematic priorities. ‘EIC Pathfinder Challenges’ to support coherent portfolios of projects within predefined thematic areas with the aim to achieve specific objectives for each Challenge. Scope: Do you have an ambitious vision for a novel future technology that could make a real difference to our lives? Do you see a plausible way of achieving the scientific breakthrough that will make this technology possible? Can you imagine collaborating with an interdisciplinary team of researchers and innovators to validate the scientific basis of the future technology, realise a proof of principle, and explore paths to impact? If the answer to each one of these questions is ‘yes’, then EIC Pathfinder Open may be the right call for you. You should apply if you are looking for support from EIC Pathfinder Open to realise an ambitious vision for radically new technology, with potential to create new markets, respond to societal needs and/or to provide solutions for global challenges. EIC Pathfinder Open supports early-stage development of such future technologies (e.g., various activities at low Technology Readiness Levels from 1 to 4), based on high risk/high-gain science-towards-technology breakthrough research ( ‘deep tech’). This research must provide the foundations of the technology you are envisioning. EIC Pathfinder Open may support your work, especially if it is highly risky: you may set out to try things that will not work; you may be faced with questions that nobody knows the answer to yet; you may realise that there are many aspects of the problem that you do not master. On the contrary, if the approach you want to follow is incremental by nature or known, EIC Pathfinder Open will not support you. Before applying to this call, you should verify that your proposal meets all the following essential char Programme areas: The Pathfinder for Advanced Research, The European Innovation Council (EIC), Innovative Europe, Horizon Europe (HORIZON) Keywords: PATHFINDER, PATHFINDER OPEN, PATHFINDEROPEN
ERC ADVANCED GRANTS is sponsored by European Commission — Horizon Europe. Expected Outcome: Objectives and profile of the ERC Advanced Grant Principal Investigator The objective of the Advanced Grant is to support excellent Principal Investigators that are established research leaders. An ERC Advanced Grant Principal Investigator is expected to be an active researcher with a track record of significant research achievements. Size of ERC Advanced Grants Advanced Grants may be awarded up to a maximum of EUR 2 500 000 for a period of 5 years . The maximum amount of the grants is reduced pro rata temporis for projects of a shorter duration. Additional funding up to EUR 1 000 000 * can be requested to cover further eligible costs (e.g. start-up costs, major equipment, access to large facilities, major experimental and field work costs) when these are necessary to carry out the proposed work. The requests for additional funding must be duly justified in the proposal. Additional funding is not subject to pro rata temporis reduction for projects of shorter duration. * Except for Principal Investigators in Starting, Consolidator, or Advanced Grant re-locating to the EU or an Associated Country from elsewhere to take up their ERC grant. In this case, the maximum additional funding shall be EUR 2 000 000. The Advanced Grant is awarded as a single lump sum contribution for the entirety of the project (broken down by beneficiaries – where applicable) based on a realistic estimate of the actual cost of the project, and fully covering the work to be implemented in the proposed action. For further information, please see the ERC Work Programme 2026 . Programme areas: Horizon Europe (HORIZON), Excellent Science, European Research Council (ERC) Keywords: Advanced Grant, ERC, European Research Council, Excellent Science, Frontier Research
Training and innovation networks for sustained capacity development related to ethics, regulatory, pharmacovigilance, and related digital regulatory platforms is sponsored by European Commission — Horizon Europe. Expected Impact: Expected Impact Through strategic capacity building, digital transformation, and cooperation in SSA, the actions funded under this topic should contribute to the establishment of a resilient and future-ready ethics, regulatory and PV environment. Applicant consortium If requested by the applicant consortia, the EDCTP Association may offer technical support for the preparation of their proposal, in particular because of the lump sum nature of the Grant Agreement. The applicant consortia may also decide to include the EDCTP Association as coordinator. In that case, the applicant consortia should contact the EDCTP Association to obtain the estimated amount of the Association’s contribution as well as any other relevant information. The EDCTP Association will timely provide the necessary information to all potential applicants. Expected Outcome: Background Ethics bodies, regulatory agencies, and pharmacovigilance (PV) systems in sub-Saharan Africa (SSA) continue to face significant challenges that hinder effective provision of healthcare services, safety reporting and timely regulatory approval for clinical trials, and marketing authorisation of products. These challenges are largely attributed to limited resources, limited training provision and access to mentor expertise, governance constraints, disparities in digital infrastructure, and limited regional and international regulatory alignment. In response, initiatives such as the African Vaccines Regulatory Forum (AVAREF), the African Medicines Regulatory Harmonization (AMRH) Programme and most recently the African Medicines Agency (AMA) have been launched to address these gaps. International bodies, including the World Health Organization (WHO), along with partnerships in SSA, have contributed to bridge the gap by offering technical support, training, and resources to strengthen ethics, regulatory and PV capacities. Public-private partnerships have further supported ethics and regulatory capacity strengthening, safety monitoring systems, including the development and integration of digital health technologies to enhance adverse event monitoring and reporting, and to accelerate the regulatory submission and assessment processes through collaborative or joint reviews. As per the WHO publication of October 2025 [1] , eight SSA National Regulatory Authorities (NRAs)—Ghana, Nigeria, South Africa, Tanzania, Rwanda, Senegal, and Zimbabwe—are classified by WHO as Maturity Level 3 (ML3), indicating reasonably established and functioning regulatory systems. Nevertheless, major hurdles remain, such as the lack of harmonised regulatory standards and timelines, underfunded research ethics committees (RECs) and NRAs, disparities in institutional and digital capacity and sustainability of the systems set up. These issues hinder the timely and consistent evaluation of research protocols and/or applications for marketing authorisation for diagnostics, medicines, and vaccines across the region. Despite the increasing participation of SSA countries in the WHO Programme for International Drug Monitoring (WHO PIDM), PV systems in many SSA countries remain underdeveloped and insufficiently integrated into national healthcare systems. This is reflected on both pre- and post-authorisation safety monitoring, where systems are weakened by poor digital infrastructure, limited laboratory capacity for confirmation of suspected events, weak reporting tools for data capture and interpretation, and a shortage of trained personnel. This limits the region’s ability to ensure effective PV and safety of medicinal products. Building on the progress made through previous EDCTP initiatives [2] , this call aims to scale and sustain these efforts by establishing training, twinning, and innovation networks, leveraging existing networks where applicable that will bolster workforce capacity in ethics, regulatory, and PV and harmonisation of processes and timelines. Central to this approach is the develop Programme areas: Horizon Europe (HORIZON), Global Challenges and European Industrial Competitiveness, Health Keywords: Artificial intelligence, Big data, Digital Services and Platforms, Digital transformation, Epidemiology, Ethics in medical sciences, Global health, Health data, Health sciences, Medical biotechnology related ethics, Medical ethics, Pharmacovigilance, Regulatory affairs, eInfrastructure, Africa, Africa CDC, Artificial Intelligence, Digital health, Digital health systems, Digital innovations, EDCTP, EDCTP3, Global Health, Innovation networks, Public health, Public health workforce, Regulatory platforms, Skilled personnel, Sub-Saharan Africa, Trainings, Twinning
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.
The EU's last major Horizon Europe work programme puts €14B on the table through 2027. A strategic breakdown of budgets, deadlines, eligibility, and how US-based teams can compete.
Read articleEUR 307M in Horizon Europe AI calls closed April 15, 2026. US researchers can participate — but the rules are specific. Here is how to navigate them.
Read articleThe EU committed €900 million to lure researchers with relocation grants worth up to €2 million each. France placed 41 of 46 recruits from the US. Here is what the global talent war means for American research institutions and grant seekers.
Read article